Skip to main content
. 2023 Jan 8;12(1):116. doi: 10.3390/antibiotics12010116

Table 2.

Characteristics of the 16 ESBL-producing E. coli isolates recovered from the fecal samples of healthy humans.

Strain Resistance Profile to Non Beta-Lactams Beta-Lactamases MLST Phylogroup PFGE Class 1 Integron Other Resistance
Genes Detected Outside Integron
IntI1/
qacEΔ1 + sul1
Gene Cassette Arrangement
3i CIP, NAL, SXT, SUL, S, TET CTX-M-15 ND A P1 +/+ aadA1 sul2, sul3, tetA
5c CIP, NAL, SUL, TET CTX-M-1 ST131 B2 P2 −/− - sul2, tetA
13c NAL, SUL, S, GN, CHL CTX-M-1 ST1158 D P3 −/− - sul2
19c SXT, SUL, S, TET CTX-M-15 ST925 D P4 −/− - sul2, tetA
25c CIP, NAL, SXT, SUL, AK, K, T, S, GN, CHL, TET CTX-M-15, TEM-1 ST5100 A P5 +/+ dfrA12-orf-aadA2 sul1, sul2, tetB
26c SUL, TET CTX-M-15 ND A P6 −/− - -
30c SXT, SUL, S, TET CTX-M-27 ST2887 D P7 −/− - sul1, sul2, tetA
32c SXT, SUL, S, RAM, CHL CTX-M-15 ND A P8 −/− - sul3
35c SXT, SUL, S, TET CTX-M-27 ND D P9 −/− - sul2, sul3, tetA
37c SXT, SUL CTX-M-15 ND A P10 +/+ dfrA5 sul2, tetA
39c SXT, SUL, S, TET CTX-M-15 ND A P11 −/− - sul2, tetA
42c SXT, SUL, S, TET CTX-M-15, TEM-1 ND A P12 +/+ dfrA12-orf-aadA2 sul2, tetA
45c SUL, K, S, TET CTX-M-27 ND D P13 −/− - sul2, tetA
46c CIP, NAL, SXT, SUL, K, T, S, GN, CHL, TET CTX-M-55 ST744 D P14 +/+ dfrA17-aadA5 sul2, tetA
47c CIP, NAL, SXT, SUL, S, TET CTX-M-15 ND A P15 −/− - sul2
49c CIP, NAL, SXT, SUL, S, TET CTX-M-1, TEM1 St7366 A P16 +/+ dfrA5 sul2, tetA

SXT: trimethoprim–sulfamethoxazole; SUL: sulphonamides; AK: amikacine; K: kanamycine; T: tobramycine, S: streptomycin, GN: gentamicin, TET: tetracycline; CHL: chloramphenicol; NAL: nalidixic acid; CIP: ciprofloxacin; ND: not done.